Results
|
1.
|
Comparison of transradial and transfemoral access in patients undergoing percutaneous coronary intervention for complex coronary lesions. MedStar authors:
- Baker, Nevin C
- Ben-Dor, Itsik
- Bernardo, Nelson L
- Escarcega, Ricardo O
- Gaglia, Michael AJ
- Gai, Jiaxiang
- Gallino, Robert
- Kiramijyan, Starkis
- Koifman, Edward
- Lager, Robert A
- Lipinski, Michael J
- Negi, Smita I
- Pichard, Augusto D
- Satler, Lowell F
- Suddath, William O
- Torguson, Rebecca
- Waksman, Ron
Year: 2017
Citation: - Catheterization & Cardiovascular Interventions. 89(4):640-646, 2017 Mar 01
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
All authors: - Baker NC, Ben-Dor I, Bernardo NL, Escarcega RO, Gaglia MA Jr, Gai J, Gallino RA, Kiramijyan S, Koifman E, Lager RA, Lipinski MJ, Negi SI, Pichard AD, Satler LF, Suddath WO, Torguson R, Waksman R
|
|
2.
|
|
|
3.
|
|
|
4.
|
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033. MedStar authors:
Year: 2017
Citation:
- JAMA Oncology. , 2017 Feb 09
- JAMA Oncology. 3(7):944-952, 2017 Jul 01
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baker LH, Benjamin RS, Blackstein ME, Blanke CD, Borden EC, Corless CL, Crowley JJ, Demetri GD, Fletcher JA, Heinrich M, Maki RG, Owzar K, Priebat DA, Rankin C, Ryan CW, Tap WD, von Mehren M
|
|
5.
|
Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus. MedStar authors:
Year: 2017
Citation: - Clinical Transplantation. 31(5), 2017 May
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Hassan M, Lalos A, Liriano-Ward L, Morales AL, Nair V, Sang M, Satoskar R, Schiano T, Smith C, Tierney A
|
|
6.
|
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5. MedStar authors:
Year: 2017
Citation: - Clinical Breast Cancer. 17(1):48-54.e3, 2017 Feb
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Ansari B, Buyse ME, Conlin AK, Geyer CE Jr, Gross HM, Jacobs SA, Keogh GP, Lord RS, Mamounas EP, Mauquoi C, Patocskai EJ, Polikoff JA, Rastogi P, Robidoux A, Smith JW 2nd, Stella PJ, Swain SM, Wolmark N
|